Clinical Trials
10
Active:10
Completed:0
Trial Phases
1 Phases
Phase 1:5
Drug Approvals
15
EMC:9
NMPA:2
CIMA_AEMPS:2
+2 more agencies
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (100.0%)No trials found
News
FDA Grants Orphan Drug Designation to COAGADEX for Rare Bleeding Disorder Associated with AL Amyloidosis
The FDA has granted Orphan Drug Designation to Kedrion Biopharma's COAGADEX for treating acquired Factor X deficiency, a rare blood disorder affecting fewer than one in one million people globally.